ArticleFEBS open bio2018

Circulating anti-p16a IgG autoantibodies as a potential prognostic biomarker for non-small cell lung cancer.

Huan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.